Evidence map›Paper›PMID 35498528›Full record

ArticleFrontiers in sports and active living2022

Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project.

Tina P Engseth, Erik P Andersson, Guro S Solli, Bente Morseth, Tor Oskar Thomassen, Dionne A Noordhof, Øyvind Sandbakk, Boye Welde

Open access · goldAbstract read
In one paragraph

Article in Frontiers in sports and active living, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Knowledge and Communication About the Menstrual Cycle Among Rhythmic Gymnasts, Ballerinas, and Dancers.International journal of environmental research and public health · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tina P EngsethSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Erik P AnderssonSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Guro S SolliSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Bente MorsethSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Tor Oskar ThomassenSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Dionne A NoordhofDepartment of Neuromedicine and Movement Science, Centre for Elite Sports Research, Norwegian University of Science and Technology, Trondheim, Norway.
Øyvind SandbakkSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
Boye WeldeSchool of Sport Sciences, UiT, The Arctic University of Norway, Tromsø, Norway.
UiT The Arctic University of Norway · NONorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate the prevalence of hormonal contraceptive (HC) use by female cross-country (XC) skiers and biathletes competing at a national and/or international level, their reasons for HC use, and to compare negative symptoms related to the HC-/menstrual cycle in HC users and non-HC users. Additionally, to characterize the self-perceived influence of HC use on training and performance. Methods: A total of 113 Norwegian competitive XC skiers and biathletes completed an online questionnaire including both closed and open-ended questions. The questions were designed to assess the type of HC, reasons for use, self-reported negative symptoms related to HC-/menstrual cycle, as well as athletes' experiences regarding how HC use affects training and performance. Results: In total, 68% of all the athletes used HC, with 64 and 36% of them using a progestin-only and combined type HC, respectively. Non-contraceptive reasons for HC use were reported by 51% of the progestin-only HC users vs. 75% of the combined HC users ( Conclusions: In total, 68% of the XC skiers and biathletes used HC, with the highest proportion (64%) using a progestin-only HC. Many athletes used HC to manipulate their menstrual cycle due to perceived negative menstrual-related symptoms that interfered with their training sessions and/or competitions.

Indexed as

combined hormonal contraceptivesendurancefemale athleteshormonal contraceptivesprogestin-only hormonal contraceptives

Identifiers

PMID35498528
PMCPMC9047044
OpenAlexW4224067206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.